IOVANCE BIOTHERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Iovance Biotherapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Iovance Biotherapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $69.1M, a 2.21% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $69.1M +$1.49M +2.21% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $71.5M +$1.09M +1.54% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $62.5M -$10.5M -14.4% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $66.3M -$2M -2.93% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $67.6M -$3.21M -4.54% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $70.4M -$3.04M -4.14% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $73M +$4.03M +5.85% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $68.3M -$4.16M -5.74% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $70.8M +$18.3M +34.9% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $73.5M +$18.3M +33.3% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $69M +$14.2M +26% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $72.4M +$61.7M +578% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $52.5M +$45M +602% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $55.1M +$45.8M +492% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $54.8M +$44.1M +412% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $10.7M -$3.06M -22.2% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $7.48M -$4.24M -36.2% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $9.31M -$652K -6.55% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $10.7M +$10.7M Dec 31, 2019 10-K 2021-02-25
Q3 2019 $13.7M Sep 30, 2019 10-Q 2019-11-04
Q2 2019 $11.7M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $9.96M Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $0 Dec 31, 2018 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.